20 Years of Experience with Methotrexate in Rheumatoid Arthritis. An Analysis from the Rhumadata® Clinical Database and Registry

被引：0
作者：
Nadon, Valerie [1 ]
Coupal, Louis [1 ]
Bessette, Louis [2 ]
Haraoui, Boulos [1 ]
Massicotte, Frederic [1 ]
Pelletier, Jean-Pierre [1 ]
Raynauld, Jean-Pierre [1 ]
Remillard, Marie-Anais [1 ]
Sauvageau, Diane [1 ]
Turcotte, Angele [3 ]
Villeneuve, Edith [1 ]
Choquette, Denis [1 ]
机构：
[1] Inst Rhumatol Montreal, Montreal, PQ, Canada
[2] Laval Univ, Quebec City, PQ, Canada
[3] Ctr Osteoporose & Rhumatol Quebec, Quebec City, PQ, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2017年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
240
引用
收藏
页码：948 / 948
页数：1
相关论文
共 50 条
  • [1] Comparing Abatacept to Adalimumab, Etanercept and Infliximab as First or Second Line Agents in Patients with Rheumatoid Arthritis. Experience from the RHUMADATA® Clinical Database and Registry
    Coupal, Louis
    Haraoui, Boulos
    Bessette, Louis
    Raynauld, Jean-Pierre
    Pelletier, Jean-Pierre
    Massicotte, Frederic
    Remillard, Marie-Anais
    Sauvageau, Diane
    Villeneuve, Edith
    Choquette, Denis
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1314 - 1314
  • [2] COMPARING ABATACEPT TO ADALIMUMAB, ETANERCEPT AND INFLIXIMAB AS FIRST OR SECOND LINE AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS. EXPERIENCE FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY
    Fortin, I.
    Choquette, D.
    Bessette, L.
    Haraoui, B.
    Pelletier, J. -P.
    Raynauld, J. P.
    Remillard, M-A
    Sauvageau, D.
    Villeneuve, E.
    Coupal, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 273 - 274
  • [3] Comparing Abatacept to Adalimumab, Etanercept and Infliximab As First Line Agents in Patients with Rheumatoid Arthritis. Experience from the Rhumadata® Clinical Database and Registry.
    Choquette, Denis
    Bessette, Louis
    Fortin, Isabelle
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Remillard, Marie-Anais
    Sauvageau, Diane
    Villeneuve, Edith
    Coupal, Louis
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S676 - S677
  • [4] Etanercept Has a Better Retention Rate at 10 Years Than Adalimumab in Patients with Rheumatoid Arthritis. Results from Rhumadata® : A Real-Life Clinical Database and Registry
    Choquette, Denis
    Bessette, Louis
    Brown, Jacques
    Haraoui, Boulos
    Massicotte, Frederic
    Pelletier, Jean-Pierre
    Raynauld, Jean-Pierre
    Remillard, Marie-Anais
    Sauvageau, Diane
    Turcotte, Angele
    Villeneuve, Edith
    Coupal, Louis
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] COMPARISON OF THE THERAPEUTIC TRAJECTORIES OF PATIENTS WITH OLIGO AND POLYARTICULAR PSORIATIC ARTHRITIS. A REPORT FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY
    Choquette, D.
    Sauvageau, L. Choquette
    Bessette, L.
    Ferdinand, I.
    Haraoui, P.
    Massicotte, F.
    Pelletier, J. P.
    Raynauld, J. P.
    Remillard, M. A.
    Sauvageau, D.
    Villeneuve, E.
    Coupal, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 753 - 754
  • [6] Biosimilar Etanercept Use in Rheumatoid Arthritis: The Rhumadata Registry Experience
    Moura, Cristiano
    Bernatsky, Sasha
    Coupal, Louis
    Bessette, Louis
    Choquette, Denis
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1107 - 1107
  • [7] Use Of Rituximab As Second Line Biologic Agent Compared With Adalimumab, Etanercept and Infliximab In Patients With Rheumatoid Arthritis. A Report From The Rhumadata® Clinical Database and Registry
    Bessette, Louis
    Choquette, Denis
    Sauvageau, Diane
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Villeneuve, Edith
    Coupal, Louis
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S187 - S187
  • [8] Comparing abatacept to Adalimumab, Etanercept and Infliximab As First Or Second Line Agents in Patients With Rheumatoid arthritis: Experience From the rhumadata® Clinical Database and Registry
    Choquette, Denis
    Sauvageau, Diane
    Bessette, Louis
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Villeneuve, Edith
    Coupal, Louis
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S186 - S186
  • [9] Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry
    Denis Choquette
    Louis Bessette
    Evo Alemao
    Boulos Haraoui
    Roelien Postema
    Jean-Pierre Raynauld
    Louis Coupal
    Arthritis Research & Therapy, 21
  • [10] Comparing Adalimumab and Etanercept As First Line Agents In Patients With Psoriatic Arthritis. Data From The Rhumadata® Clinical Database and Registry
    Hoa, Sabrina
    Choquette, Denis
    Bessette, Louis
    Sauvageau, Diane
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Villeneuve, Edith
    Coupal, Louis
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S145 - S145
12345